SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity - Yin, F; Feng, F; Wang, L; Wang, X; Li, Z; Cao, Y (Cell Death Dis, 2019)